Synthesis and biological evaluation of novel benzo[c][1, 2, 5]thiadiazol-5-yl and thieno[3, 2-c]- pyridin-2-yl imidazole derivatives as ALK5 inhibitors. Issue 16 (15th August 2019)
- Record Type:
- Journal Article
- Title:
- Synthesis and biological evaluation of novel benzo[c][1, 2, 5]thiadiazol-5-yl and thieno[3, 2-c]- pyridin-2-yl imidazole derivatives as ALK5 inhibitors. Issue 16 (15th August 2019)
- Main Title:
- Synthesis and biological evaluation of novel benzo[c][1, 2, 5]thiadiazol-5-yl and thieno[3, 2-c]- pyridin-2-yl imidazole derivatives as ALK5 inhibitors
- Authors:
- Guo, Zhen
Song, Xiaowei
Zhao, Li-Min
Piao, Ming Guan
Quan, Jishan
Piao, Hu-Ri
Jin, Cheng Hua - Abstract:
- Graphical abstract: Effect of compound 14c on TGF-β1-induced Smad2 phosphorylation. Highlights: Two series of imidazole derivatives were designed and synthesized. Compound 14c showed 16.1-fold and 1.8-fold activity of clinical candidates LY-2157299 and EW-7197, respectively. Anticancer activity evaluation of 14c was performed against SPC-A1, HepG2 and HUVEC cells. Abstract: Transforming growth factor (TGF-β), a key mediator of tumor growth and metastasis, has been recognized as an important cancer drug target. A series of benzo[ c ][1, 2, 5]thiadiazol-5-yl imidazoles (14a –g ) and thieno[3, 2- c ]-pyridin-2-yl imidazoles (20a –g ) were designed, synthesized, and evaluated for their activin receptor-like kinase 5 (ALK5) activities. Among these compounds, 14c showed the highest activity (IC50 = 0.008 μM) against ALK5 kinase, which was 16.1-fold and 1.8-fold higher than those of positive control compounds LY -2157299 (IC50 = 0.129 μM) and EW-7197 (IC50 = 0.014 μM), respectively. Compound 14g (350) showed the highest selectivity index of ALK5 against p38α MAP kinase, which was significantly higher than that of positive control compounds LY -2157299 (4) and EW -7197 (211). The inhibitory effects of compound 14c on TGF-β-induced Smad signaling and cell motility were studied in SPC-A1, HepG2 and HUVEC cells using western blot analysis and wound healing assay. ADMET prediction analysis showed that compounds 14c and 14g had good pharmacokinetics and drug-likeness behaviors.
- Is Part Of:
- Bioorganic & medicinal chemistry letters. Volume 29:Issue 16(2019)
- Journal:
- Bioorganic & medicinal chemistry letters
- Issue:
- Volume 29:Issue 16(2019)
- Issue Display:
- Volume 29, Issue 16 (2019)
- Year:
- 2019
- Volume:
- 29
- Issue:
- 16
- Issue Sort Value:
- 2019-0029-0016-0000
- Page Start:
- 2070
- Page End:
- 2075
- Publication Date:
- 2019-08-15
- Subjects:
- ALK5 -- TGF-β -- Imidazole -- Inhibitors -- ADMET
Bioorganic chemistry -- Periodicals
Pharmaceutical chemistry -- Periodicals
572 - Journal URLs:
- http://www.elsevier.com/wps/find/journaldescription.cws_home/972/description#description ↗
http://www.sciencedirect.com/science/journal/0960894X ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.bmcl.2019.07.015 ↗
- Languages:
- English
- ISSNs:
- 0960-894X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2089.330000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 14233.xml